Celldex Therapeutics
CLDX
#4450
Rank
ยฃ1.94 B
Marketcap
ยฃ24.81
Share price
-0.24%
Change (1 day)
65.95%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ1.44 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is ยฃ1.44 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ1.73 M-42.91%
2024-12-31ยฃ3.03 M52.28%
2023-12-31ยฃ1.99 M-40.15%
2022-12-31ยฃ3.33 M47.92%
2021-12-31ยฃ2.25 M-11.75%
2020-12-31ยฃ2.55 M-8.43%
2019-12-31ยฃ2.78 M
2018-12-31N/A-100%
2017-12-31ยฃ4.85 M
2015-12-31ยฃ2.98 M79.07%
2014-12-31ยฃ1.66 M
2013-12-31N/A-100%
2012-12-31ยฃ7.01 M-28%
2011-12-31ยฃ9.74 M39.04%
2010-12-31ยฃ7 M-18.06%
2009-12-31ยฃ8.55 M5649.97%
2008-12-31ยฃ0.14 M-94.28%
2007-12-31ยฃ2.6 M9.75%
2006-12-31ยฃ2.37 M95.8%
2005-12-31ยฃ1.21 M1146.04%
2004-12-31ยฃ0.09 M
2000-12-31ยฃ0.18 M-47.21%
1999-12-31ยฃ0.34 M-63.8%
1998-12-31ยฃ0.96 M-1.21%
1997-12-31ยฃ0.97 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ48.13 B 3,340,046.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.29 B 3,004,250.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ19.06 B 1,322,562.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
ยฃ85.71 M 5,847.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ34.57 M 2,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.50 B 34,653.67%๐Ÿ‡บ๐Ÿ‡ธ USA